If we can go right to the freezer and pull out a vaccine that we've already tested and show it will protect against multiple strains, then we could actually go right into commercial manufacturing and start making vaccine 3-6 months sooner.
An intranasal pandemic vaccine may help facilitate and expedite influenza vaccinations for more Americans in the event of a pandemic outbreak.
It's our technology, with their knowledge of the preclinical side and our ability to ultimately go through the regulatory process and manufacture large quantities of vaccine that would make this marriage work.